Back to search

Article

Solute carrier family 47 member 1 gene polymorphism detection improves the therapeutic effect of diabetes.

2024-01-30

Abstract excerpt

Abstract: Purpose: To explore the impact of SLC47A1 ( Solute carrier family 47 member 1, SLC47A1 ) gene polymorphism on the treatment of diabetes, we conducted a statistical analysis of the SLC47A1 genetic testing results and patient data in the second quarter of 2019 in our hospital. <h4>Methods:</h4> We investigated 372 cases of SLC47A1 gene test reports and patient medical records, collected information on gend...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b904c6cf-ca19-5231-b45d-e5c074cf1b17
DOI
10.22541/au.170665365.51917389/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Solute carrier family 47 member 1 gene polymorphism detection improves the therapeutic effect of diabetes.DOI 10.22541/au.170665365.51917389/v1
Pharmacogenomic association between a variant in SLC47A1 gene and therapeutic response to metformin in type 2 diabetes.Semantic proximity
SLC47A1 gene rs2289669 G>A variants enhance the glucose-lowering effect of metformin via delaying its excretion in Chinese type 2 diabetes patients.Semantic proximity
Influence of Solute Carrier Family 22 Member 1 (SLC22A1) Gene Polymorphism on Metformin Pharmacokinetics and HbA1c Levels: A Systematic Review.Semantic proximity
Identification of clinical and pharmacogenetic factors influencing metformin response in Type 2 diabetes mellitus.Semantic proximity
Impact of SLC22A1 variants rs622342 and rs72552763 on HbA1c and metformin plasmatic concentration levels in patients with type 2 diabetes mellitusSemantic proximity
Clinical Study on the Relationship between the SNP rs8192675 (C/C) Site of SLC2A2 Gene and the Hypoglycemic Effect of Metformin in Type 2 Diabetes.Semantic proximity
Association of SLC22A1, SLC22A2, SLC47A1, and SLC47A2 Polymorphisms with Metformin Efficacy in Type 2 Diabetic PatientsSemantic proximity
Pharmacogenetic impact of SLC22A1 gene variant rs628031 (G/A) in newly diagnosed Indian type 2 diabetes patients undergoing metformin monotherapy.Semantic proximity
Metformin Pharmacogenetics: Effects of SLC22A1, SLC22A2, and SLC22A3 Polymorphisms on Glycemic Control and HbA1c LevelsSemantic proximity
Implication of critical pharmacokinetic gene variants on therapeutic response to metformin in Type 2 diabetes.Semantic proximity
The Impacts of<i>SLC22A1</i>rs594709 and<i>SLC47A1</i>rs2289669 Polymorphisms on Metformin Therapeutic Efficacy in Chinese Type 2 Diabetes PatientsSemantic proximity
Transporters, TBC1D4, and ARID5B Variants to Explain Glycated Hemoglobin Variability in Patients with Type 2 Diabetes.Semantic proximity
Select a neighboring publication to make it the new centre.